Current Neuro-Oncology

Volume 27 Number 20
20 July 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 20, 20 July

*Bonucci M, Fuggetta MP, Anelli L, Giannarelli D, Fiorentini C, Ravagnan G.
New Approach for Enhancing Survival in Glioblastoma Patients: A Longitudinal Pilot Study on Integrative Oncology.
Cancers (Basel). 2025 Jul 12;17(14):2321. doi: 10.3390/cancers17142321. PMID: 40723205. Observational study. ˍ

Ding X, Chen D, Zhang Z, Qi Y, Chen D, Wen J, Wang Y, Cheng H, Ji C, Chen L, Tang C, Yao Y.
Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical Trial.
Clin Med Insights Oncol. 2025 Jul 13;19:11795549251350188. doi: 10.1177/11795549251350188. PMID: 40661859. Interventional study. ˍ ClinicalTrials.gov ID: NCT02263105.

Jung Y, Dirks J, Hawkins C, Tabori U, Das A, Bennett J, Dirks P, Quon JL.
A role for early surgical intervention in childhood low-grade glioma? Illustrative case.
J Neurosurg Case Lessons. 2025 Jul 14;10(2):CASE2584. doi: 10.3171/CASE2584. PMID: 40658996. Case report. ˍ

Prosperetti C, Yenigün M, Pagnamenta A, Tabaee Damavandi P, Disanto G, Marchi F, Espeli V, Muoio B, Spina P, Pesce G, Agazzi P.
Sex-Related Differences in Glioblastoma: A Single-Center Retrospective Cohort Study.
Biomedicines. 2025 Jul 14;13(7):1715. doi: 10.3390/biomedicines13071715. PMID: 40722784. Observational study. ˍ

Sumita K, Sawada M, Hattori EY, Sano N, Takada S, Tanji M, Mineharu Y, Kikuchi T, Arakawa Y.
Diffuse midline glioma H3K27-altered with thoracic epidural metastasis: illustrative case.
J Neurosurg Case Lessons. 2025 Jul 14;10(2):CASE25249. doi: 10.3171/CASE25249. PMID: 40658994. Case report. ˍ

Haisraely O, Vedala S, Al-Sharfeen A, Manzar GS, Perni S, Tom MC, Beckham TH, Wang C, Yeboa DN, Chung C, McAleer MF, Ghia AJ, Ene CI, Weathers SP, McGovern SL, Wogan CF, Roth M, Li J, De B.
Glioblastoma in young adult patients: contemporary patterns of care and survival in the United States.
J Neurooncol. 2025 Jul 15. doi: 10.1007/s11060-025-05135-5. PMID: 40663309. Observational study˰ ˍ

Comer C, Cotton K, Edwards C, Dai X, Badodi S, Buccafusca R, Bennett C, Peet A, Williams A, Michod D, Bochukova E, Niklison-Chirou MV.
Simvastatin suppresses spinal cord metastasis of medulloblastoma at clinically significant doses.
Cell Death Dis. 2025 Jul 15;16(1):527. doi: 10.1038/s41419-025-07829-0. PMID: 40664675. Lab investigation. ˍ

Lü MJS, Michaelsen SR, Locallo A, Eickhart-Dalbøge CS, Scheie D, Melchior LC, Weischenfeldt J, Lassen U, Poulsen HS, Urup T.
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study.
J Neurooncol. 2025 Jul 16. doi: 10.1007/s11060-025-05162-2. PMID: 40668315. Observational study. ˍ

Liu PC, Kuo CY, Chen YW, Lin CF, Lin SC, Chang FC, Chen MT, Wu JC, Lee YY.
Bevacizumab alternating chemotherapy for improving the survival of patients with recurrent high-grade glioma.
Neurooncol Adv. 2025 Jul 18;7(1):vdaf157. doi: 10.1093/noajnl/vdaf157. PMID: 40746950. Observational study. ˍ

Whittle JR, Vieito M, Rohrberg K, Rodriguez-Ruiz ME, Castanon E, Mellinghoff IK, Van Linde M, Cloughesy T, Reardon DA, Chong RA, Rosenthal M, Wick A, Waldhauer I, Henkel N, Romagnoli B, Wolowski V, Dey S, Heil F, Heichinger C, Flinn N, Gou JP, Smith L, Prince F, Derks M, Roller A, Schiff C, Schneider M, Mason W.
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma.
Neurooncol Adv. 2025 Jul 18;7(1):vdaf160. doi: 10.1093/noajnl/vdaf160. PMID: 40842640. Interventional study. ˍ ClinicalTrials.gov ID: NCT05187624.